Genomic Testing for Improved Treatments in Breast Cancer

Experts Joyce O’Shaughnessy, MD, and Erin Cobain, MD, review the clinical evolution of treatments in early-stage breast cancers, highlighting the latest data in genomic testing presented at the SABCS 2023 annual congress.

EP. 1: Evolving Treatment Paradigms for Early-Stage Breast Cancers

December 20th 2023

Expert insights into the evolving therapeutic landscape for early-stage breast cancers, emphasizing targeted therapies and genomic testing for personalized treatment paradigms.

EP. 2: Overview of Genomic Assays for Early-Stage Breast Cancer

February 8th 2024

A comprehensive overview of genomic assays conducted for patients with early-stage breast cancer including MammaPrint, BluePrint, Oncotype DX.

EP. 3: MammaPrint: A 70-Gene Signature Test for Patient with Breast Cancer

February 8th 2024

Dr. O’Shaughnessy introduces MammaPrint and BluePrint, discussing their role in genomic testing for patients with breast cancer.

EP. 4: Clinical Considerations of Genomic Testing in Early-Stage Breast Cancer

February 8th 2024

A discussion on clinical considerations for genomic testing in patients with early-stage breast cancer.

EP. 5: FLEX Trial: Genomic Testing of HER2 Status in ER+/HER2-Breast Cancer

February 13th 2024

Expert oncologists discuss genomic testing for patients with HER2-low breast cancer, noting the FLEX trial of MammaPrint and BluePrint.

EP. 6: Exploring Multigene Genomic Assays in High-Risk BC Patients

February 13th 2024

Dr. O’Shaughnessy details the genomic assay MammaPrint and how it compares to other multigene assays used in practice, highlighting the MINDACT and TAILORx trials.

EP. 7: Real-World Evidence in Genomic Testing from SABCS 2023

February 20th 2024

Experts in breast cancer outline data presented at SABCS 2023, focusing on real-world evidence for genomic assays used in practice.

EP. 8: Racial Disparities and Genomic Testing for Breast Cancer Patients

February 20th 2024

Dr O’Shaughnessy and Dr Cobain review growing discussions from SABCS 2023 surrounding the impact of racial disparities and genomic testing for breast cancer patients.

EP. 9: Reflecting on Genomic Testing in Practice for Breast Cancer

February 27th 2024

Joyce O’Shaughnessy, MD and Erin Cobain, MD, offer their reflections of genomic testing in breast cancer and its impact on clinical practice.

EP. 10: Ongoing Studies in Genomic Testing for Breast Cancer

February 27th 2024

Closing their discussion, experts share ongoing studies utilizing genomic testing for patients with breast cancer.